Bolliger M, Wasinger D, Brunmair J, Hagn G, Wolf M, Preindl K
EPMA J. 2025; 16(1):165-182.
PMID: 39991101
PMC: 11842658.
DOI: 10.1007/s13167-025-00396-6.
Harkos C, Hadjigeorgiou A, Voutouri C, Kumar A, Stylianopoulos T, Jain R
Nat Rev Cancer. 2025; .
PMID: 39972158
DOI: 10.1038/s41568-025-00796-w.
Ha H, Choi Y, Kim N, Kim J, Jang J, Niepa T
Biomater Res. 2025; 29:0144.
PMID: 39935791
PMC: 11811622.
DOI: 10.34133/bmr.0144.
Velez Salazar F, Patino I
PLoS One. 2025; 20(2):e0315194.
PMID: 39919263
PMC: 11805580.
DOI: 10.1371/journal.pone.0315194.
Mei X, Uribe Estrada M, Rizwan M, Lukin I, Sanchez Gonzalez B, Marin Canchola J
Mater Today Bio. 2025; 31:101449.
PMID: 39896287
PMC: 11782996.
DOI: 10.1016/j.mtbio.2025.101449.
Tumour hypoxia in driving genomic instability and tumour evolution.
Suvac A, Ashton J, Bristow R
Nat Rev Cancer. 2025; 25(3):167-188.
PMID: 39875616
DOI: 10.1038/s41568-024-00781-9.
Application of MMP-2-responsive forming injectable hydrogel in preventing the recurrence of oral squamous cell carcinoma.
Li W, Wang Y, Miao H, Yan M, Liu C, Wang Y
RSC Adv. 2025; 15(3):1507-1513.
PMID: 39831041
PMC: 11740019.
DOI: 10.1039/d4ra06120a.
Mechanobiology of 3D cell confinement and extracellular crowding.
Da Silva Andre G, Labouesse C
Biophys Rev. 2025; 16(6):833-849.
PMID: 39830117
PMC: 11735831.
DOI: 10.1007/s12551-024-01244-z.
Innovative Approaches to Brain Cancer: The Use of Magnetic Resonance-guided Focused Ultrasound in Glioma Therapy.
Cwiklinska A, Przewodowska D, Koziorowski D, Szlufik S
Cancers (Basel). 2025; 16(24.
PMID: 39766134
PMC: 11674718.
DOI: 10.3390/cancers16244235.
Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review).
Zhou S, Sun J, Zhu W, Yang Z, Wang P, Zeng Y
Oncol Rep. 2025; 53(2.
PMID: 39749693
PMC: 11715622.
DOI: 10.3892/or.2024.8862.
Adaptable Manufacturing and Biofabrication of Milliscale Organ Chips With Perfusable Vascular Beds.
Byrne C, Martier A, Kpeli G, Conrad K, Bralower W, Olsen E
Biotechnol J. 2024; 19(12):e202400550.
PMID: 39711093
PMC: 11664230.
DOI: 10.1002/biot.202400550.
What is the best time of the month to treat breast cancer?.
Ingman W
Nature. 2024; 637(8044):39-41.
PMID: 39633123
DOI: 10.1038/d41586-024-03847-8.
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.
Kesharwani P, Halwai K, Jha S, Mughram M, Salman Almujri S, Almalki W
Mol Cancer. 2024; 23(1):244.
PMID: 39482651
PMC: 11526716.
DOI: 10.1186/s12943-024-02163-z.
Biodegradable ICG-Conjugated Germanium Nanoparticles for Near-Infrared Dual-Modality Imaging and Photothermal Therapy.
Chen G, He P, Ma C, Xu J, Su T, Wen J
ACS Appl Mater Interfaces. 2024; 16(44):59752-59764.
PMID: 39446048
PMC: 11551961.
DOI: 10.1021/acsami.4c10800.
Advancements in hydrogel-based embolic agents: Categorized by therapeutic mechanisms.
Zhang S, Lv R, Zhang Z, Wang Z, Jin Z
Cancer Med. 2024; 13(20):e70183.
PMID: 39440706
PMC: 11497111.
DOI: 10.1002/cam4.70183.
Direct visualization of emergent metastatic features within an ex vivo model of the tumor microenvironment.
Anandi L, Garcia J, Ros M, Janska L, Liu J, Carmona-Fontaine C
Life Sci Alliance. 2024; 8(1).
PMID: 39419548
PMC: 11487089.
DOI: 10.26508/lsa.202403053.
Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy.
Xiao Y, Pan T, Da W, Liu Y, Chen S, Chen D
Signal Transduct Target Ther. 2024; 9(1):272.
PMID: 39397032
PMC: 11471780.
DOI: 10.1038/s41392-024-01973-3.
Personalized PDAC chip with functional endothelial barrier for tumour biomarker detection: A platform for precision medicine applications.
Goluba K, Parfejevs V, Rostoka E, Jekabsons K, Blake I, Neimane A
Mater Today Bio. 2024; 29:101262.
PMID: 39381267
PMC: 11460472.
DOI: 10.1016/j.mtbio.2024.101262.
Microbubbles bound to drug-eluting beads enable ultrasound imaging and enhanced delivery of therapeutics.
Owen J, Negussie A, Burks S, Delgado J, Mikhail A, Rivera J
Sci Rep. 2024; 14(1):20929.
PMID: 39251665
PMC: 11383944.
DOI: 10.1038/s41598-024-71831-3.
Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity.
Singh S, Calvo R, Kumari A, Sable R, Fang Y, Tao D
Mol Cancer Ther. 2024; 23(12):1827-1841.
PMID: 39212669
PMC: 11612619.
DOI: 10.1158/1535-7163.MCT-23-0790.